|
CN109971756A
|
|
The siRNA and its precursor that inhibit EGFR to express and application
|
|
CN110016501A
|
|
Marker, detection method and its application of unexplained fever
|
|
CN107345230A
|
|
A kind of siRNA of suppression K-RAS gene expressions and its precursor and application
|
|
US2018223277A1
|
|
Precursor miRNA and applications in tumor therapy thereof
|
|
CN107345231A
|
|
A kind of siRNA for suppressing EGFR gene expression and its precursor and application
|
|
CN106978398A
|
|
A kind of exogenous tiny RNA prepares method of multipotential stem cell and application thereof
|
|
CN106978444A
|
|
A kind of method that nucleic acid is imported into cell
|
|
CN106636086A
|
|
siRNA capable of interfering hepatitis B virus replication, construction method and applications thereof
|
|
CN106267239A
|
|
A kind of screening of medicaments or the method evaluating drug effectiveness
|
|
CN106177990A
|
|
A kind of new precursor miRNA and the application in oncotherapy thereof
|
|
CN105664154A
|
|
Method of reducing tissue and/or organ transplantation immunological rejection and application thereof
|
|
CN105671072A
|
|
Preparation method and applications of transgenic plant containing anti-miRNA-214
|
|
CN105613568A
|
|
Biological pesticide using siRNA and taking plant as generator
|
|
CN105561337A
|
|
Placentalpermeable small RNA and application thereof
|
|
CN105586341A
|
|
siRNA, complementary oligomeric DNA, PGC-1 inhibitor, preparing method of the PGC-1 inhibitor and uses of the inhibitor
|
|
CN105396143A
|
|
MiRNA of specificity of Ebola virus and method for inhibiting Ebola virus through miRNA
|
|
CN105287611A
|
|
Application of ginsenoside Rh2 to inhibition of Treg cells
|
|
CN104805085A
|
|
Tandem expressed siRNA and use of tandem expressed siRNA in treatment on chronic lymphocytic leukemia
|
|
CN104805082A
|
|
Method for preparing anti-hepatitis C virus small interfering ribonucleic acid
|
|
CN104789641A
|
|
Animal response type gene under microbial infection, identification and applications thereof
|
